Diversified offering reinforces commitment to medical
customers
SMITHS FALLS, ON, Nov. 1, 2018 /CNW/ - Spectrum Cannabis Inc.
("Spectrum Cannabis"), wholly-owned subsidiary of Canopy Growth
Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth"), is pleased
to announce that it has added dried cannabis products from Craft
Grow partner James E. Wagner Cultivation ("JWC") (TSXV: JWCA) to
its online store, reinforcing its commitment to quality and
variety for its registered medical customers.
JWC is a Licensed Producer based in Kitchener, Ontario. It began as a family
business and is focused on clean, consistent, aeroponically-grown
cannabis using its proprietary technology platform,
GrowthSTORMTM.
"As cannabis markets evolve in Canada, our medical customers will continue to
be a priority. Offering a diverse selection of cannabis, including
products from trusted partners like JWC, helps ensure the varied
needs of our patient base can be met," said Mark Zekulin, President and Co-CEO, Canopy
Growth.
Products offered through verified third-party partners ensure a
win-win-win scenario for Spectrum Cannabis, medical cannabis
partners and, most importantly, its medical customers. Through this
relationship, Spectrum Cannabis diversifies its online offering,
customers get more variety, and JWC gains access to the largest
medical customer base in Canada.
JWC is the third Licensed Producer to sell its products
through the Spectrum Cannabis online store and its first available
product is its high-CBD strain "Cannatonic". In the near future,
JWC anticipates that several of its THC-dominant strains will also
become available for customers registered to the Spectrum Cannabis
online store.
In addition to offering a high variety of products in its store,
including discreet, precisely dosed Softgel capsules, Spectrum
Cannabis is committed to medical customers by covering the cost of
the federal excise tax on Spectrum Cannabis branded products, by
continuing to offer its first of its kind Compassionate Pricing
program to eligible customers, and by keeping the price of its
dried flower products at $8.50 a gram
or lower.
Spectrum Cannabis: Medical Cannabis.
Simplified.TM
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp
company, offering distinct brands and curated cannabis varieties in
dried, oil and Softgel capsule forms. From product and process
innovation to market execution, Canopy Growth is driven by a
passion for leadership and a commitment to building a world-class
cannabis company one product, site and country at a time. The
Company has operations in 12 countries across five continents. The
Company is proudly dedicated to educating healthcare practitioners,
conducting robust clinical research, and furthering the public's
understanding of cannabis, and through its wholly owned subsidiary,
Canopy Health Innovations, has devoted millions of dollars toward
cutting edge, commercializable research and IP development. Through
partly owned subsidiary Canopy Rivers Corporation, the Company is
providing resources and investment to new market entrants and
building a portfolio of stable investments in the sector. From our
historic public listing on the Toronto Stock Exchange and New York
Stock Exchange to our continued international expansion, pride in
advancing shareholder value through leadership is engrained in all
we do at Canopy Growth. Canopy Growth has established partnerships
with leading sector names including cannabis icon Snoop Dogg,
breeding legends DNA Genetics and Green House seeds, and Fortune
500 alcohol leader Constellation Brands, to name but a few. Canopy
Growth operates ten licensed cannabis production sites with over
4.3 million square feet of production capacity, including over
500,000 square feet of GMP certified production space. For more
information visit
www.canopygrowth.com
About Spectrum Cannabis
Spectrum Cannabis, a
wholly-owned subsidiary of Canopy Growth, is dedicated to
simplifying medical cannabis for patients and healthcare
practitioners. Spectrum Cannabis is an international medical
business which interfaces with healthcare professionals and
patients around the world. Founded in Canada, Spectrum Cannabis operates in
Australia, South America, Africa and across Europe. Spectrum Cannabis products are
available in a wide range of potencies and formats designed to
simplify the dialogue around strength and dosage by applying a
colour-coded Spectrum to categorize medical cannabis according to
THC and CBD levels. Its product lineup includes whole flower
cannabis, oils and new innovations such as Softgels. Through
product simplification, easy dosing formats, and ongoing education
of healthcare professionals, Spectrum is committed to improving the
lives of medical cannabis patients around the globe.
Notice Regarding Forward Looking Statements
This news
release contains "forward-looking statements" within the meaning of
the United States Private Securities Litigation Reform Act of 1995
and "forward-looking information" within the meaning of applicable
Canadian securities legislation. Often, but not always, forward
looking statements and information can be identified by the use of
words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements or information involve known and unknown
risks, uncertainties and other factors which may cause the actual
results, performance or achievements of Canopy Growth or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release. Examples of such statements include statements with
respect to product availability and variety through
Spectrumcannabis.com. Risks, uncertainties and other factors
involved with forward-looking information could cause actual
events, results, performance, prospects and opportunities to differ
materially from those expressed or implied by such forward-looking
information, including the Company's ability to satisfy provincial
sales contracts or provinces purchasing all cannabis allocated to
them, and such risks contained in the Company's annual information
form dated June 28, 2018 and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. Although the Company
believes that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this
news release are reasonable, undue reliance should not be placed on
such information and no assurance can be given that such events
will occur in the disclosed time frames or at all. The
forward-looking information and forward-looking statements included
in this news release are made as of the date of this news release
and the Company does not undertake an obligation to publicly update
such forward-looking information or forward-looking information to
reflect new information, subsequent events or otherwise unless
required by applicable securities laws.
SOURCE Canopy Growth Corporation